Drug Compounder Shut Down After FDA Flags Potential Contamination

Drug GMP Report
A A
A federal judge shut down a Salt Lake City drug compounder Aug. 3 under a consent decree issued in a case brought by the FDA after inspections uncovered numerous regulatory violations.

To View This Article:

Login

Subscribe To Drug GMP Report